Source: NaviFUS

NaviFus is proud to announce NaviFUS® Model 101 has been chosen for the 2022 Edison Awards Finalists in Outpatient Treatment.

The Finalists of the 2022 Edison Best New Product Awards® were chosen as the “best of the best” by 3000 of the world’s top senior business executives, academics, and innovation professionals.

"NaviFUS® is a focused ultrasound technology platform that provides personalized and transformative solutions for brain diseases like glioblastoma and epilepsy. It can non-invasively open the blood-brain-barrier to allow large-molecular weight drug delivery to previously unreachable parts of the brain and suppress seizures in epilepsy patients."

See the finalists of 2022 Edison Awards

More details on the NaviFUS system